Come by Our Booth at the 2021 GCSG Virtual Conference — Register Here!

Our Vision:

Advancing Clinical Trials

It’s Our Mission to use the practice of pharmacy to make clinical trials a viable healthcare option for Everyone, Everywhere™. With this new way of thinking, we can address the long-standing time, cost, and quality issues that have afflicted the industry for over 40 years.

A New Way of Thinking

Expanding The Role Of The Pharmacist

The concept of E2 Services took shape when RxE2 looked at the services provided by pharmacies and the relationship the pharmacists have with their patients through the lens of clinical research. E2 Services are pharmacy-focused, decentralized, and convenient for people everywhere. More than 85% of the population has never participated in a clinical trial, yet almost everyone has been to a pharmacy. E2 Services expand the opportunity to participate in clinical trials to more people by bringing the trials to them.

By focusing on what benefits Everyone, Everywhere, E2 Services address the time, cost, and quality issues that have persisted in the pharmaceutical clinical research industry for the past 40 years.

AI Powered,
Pharmacist-Led

Clinical Trials

RxE2 Pharmacists are pioneering a new standard for time, cost, and quality for the pharmaceutical industry.

5/10 Drugs Approved

E2 Counseling leverages the expertise of RxE2 Pharmacists to gather better information, leading to a 50% approval rate for new drugs.

5-7 Years for Approval

E2 Trials is a new framework for drug approval. RxE2 Pharmacists engage patients, capture medication data, and improve communication—reducing approval timelines by 40%

< $0.5B Development Cost

E2 Trials will commoditize clinical services, delivering results at a fraction of the cost of the traditional clinical trial model.

RxE2 Empowers Pharmacists

Why Choose RxE2 Clinical Services?

RxE2 is a disruptive company that is willing to find new solutions for clinical research. We see the industry through the eyes of pharmacists and their patients, bridging the gap between clinical research and real-world medication practices. We are the first company to fully integrate the practice of pharmacy into clinical research. Our unique model provides a new method for companies looking to make a difference, especially for companies looking to perform virtual, siteless, or decentralized trials, and for those companies seeking to truly understand patient centricity.

Why Use Pharmacies and Pharmacists?

The current practice of pharmacy is changing. Today’s pharmacies and pharmacists represent untapped resources. Pharmacies are ideally situated, as they are not only located throughout the US and the rest of the world, but they are also convenient to patients who will participate in clinical trials. Each of these pharmacies have pharmacists whose skills and expertise are often underused; skills and expertise which make the pharmacist the perfect healthcare professional to dispense clinical supplies and ensure medication adherence and compliance. More importantly, many clinical research stakeholders often overlook the relationships that pharmacists have with their patients. Those relationships, however, are the primary reason why pharmacists are, time and again, listed as one of the most trusted professionals in the US. RxE2 embraces those close relationships between pharmacists and patients, leveraging them to simultaneously improve recruitment and clinical trial outcomes.

Why is E2 the Key to Decentralized Trials?

E2 Services incorporate the practice of pharmacy and use pharmacies and pharmacists located in every corner of the US, the EU, and the world. RxE2 has created a network of pharmacists that are trained and certified as Clinical Trial Research Pharmacists (CTRPs) to provide timely and effective recruitment services for their patients. RxE2 has also created an innovative and cost-effective new system to get clinical supplies packaged, labeled, and shipped directly to those local patients. The success of decentralized trials hinges on quality. Whether it is data collection, understanding patient behaviors, addressing patient clinical supply and technology issues, or study outcomes, ensuring quality is paramount in any decentralized trial. RxE2 uses its CTRP services and propriety systems, which have been proven to improve patient care and medication outcomes, to ensure quality at every step.

Our Leadership Team

A Message From Our CEO

I am pleased that you have an interest in working with us and learning more about RxE2 and our E2 services. We are excited for the opportunity to work with you and to be able to provide patients the healthcare option of participating in your clinical trial.

I look forward to receiving your email or answering your questions and discussing how we can work together to address your needs.

Gerald E. Finken
CEO & Pharmacist

AI Powered,
Pharmacist-Led

Clinical Trials

RxE2 Pharmacists are pioneering a new standard for time, cost, and quality for the pharmaceutical industry.

5/10 Drugs Approved

E2 Counseling leverages the expertise of RxE2 Pharmacists to gather better information, leading to a 50% approval rate for new drugs.

5-7 Years for Approval

E2 Trials is a new framework for drug approval. RxE2 Pharmacists engage patients, capture medication data, and improve communication—reducing approval timelines by 40%

< $0.5B Development Cost

E2 Trials will commoditize clinical services, delivering results at a fraction of the cost of the traditional clinical trial model.

RxE2 is Everyone Everywhere™

RxE2 uses the practice of pharmacy to make clinical trials a viable healthcare option for Everyone, Everywhere, and addresses the long-standing time, cost, and quality issues that have afflicted the industry for over 40 years.

Gerald E. Finken, R.Ph., M.S.
CEO & Pharmacist

Gerald is a licensed pharmacist with almost 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO. Gerald focuses on innovation, disruptive business strategies, and growth opportunities.

Yaniv Zilberman
Chief Operating Officer

Yaniv has 20 years in executive roles in leading enterprise software solutions like SAP, LivePerson and Amdocs, with vast experience in building innovative, technology-based organizations for accelerated growth. Yaniv was the co-founder and CEO of Habitu (acquired by RxE2), an AI based solution applying Distributed Trial Management across life-routines and points-of-care. Before founding Habitu, Yaniv led global Professional Services organization as VP PS in Pontis (acquired by Amdocs) with hundreds of professionals providing solution delivery and customer success to Fortune 500 companies.

Tina Schlecht, PharmD, MBA
Chief Pharmacy Officer

Tina joined RxE2 as vice president, pharmacy operations in 2020. She brings with her over 20 years of experience in pharmacy and the biotechnology and pharmaceutical industries. She began her career at Clinical Supplies Management, Inc. (CSM) where she led the growth of Clinical Trials Research Pharmacist (CTRP®) services. She went on to serve as president of Center Point Clinical Services. During her career, she was also employed by the National Community Pharmacists Association, heading the Long-Term Care Division and working on strategic programs, and ProPharma Group, overseeing ICSR (individual case safety reports) processing and regulatory submissions for serious adverse events. Tina received her Bachelor of Science and Doctor of Pharmacy degrees from North Dakota State University and her MBA from the University of Oregon. Her pharmacy practice experience includes community and outpatient pharmacy in addition to clinical research.

Yoav Grinstein
Chief Product & Strategy Officer

Yoav has served in a variety of operational and technological roles in medical device and pharma companies. He started as a Information Technology & Systems Manager in a medical device company. In his role Yoav was leading the development and implementation of ERP, CRM and analytics solutions. Following performed several years in consulting, managing technological evaluation and implementation projects in various industries as in high-tech, life science, banks, etc. Yoav performed various roles at Teva pharmaceuticals for approximately 10 years part of Teva’s clinical development group supporting hundreds of clinical trials. Yoav managed Teva’s clinical data management systems solutions taking part in submissions to the FDA and EMEA, regulatory audits and technology development in a regulatory environment. Led the Global clinical supply chain, a large and complex operation in a dynamic environment. Also lead global Business Operations, an organization aimed on solving technological problems for Teva’s trials, implementation of trials design solutions, advanced AI prediction, clinical innovations, Teva strategic partnerships with CROs, etc.

About Us

Our Leadership Team

It’s Our Mission to use the practice of pharmacy to make clinical trials a viable healthcare option for Everyone, Everywhere. With its new way of thinking, we can address the long-standing time, cost, and quality issues that have afflicted the industry for over 40 years.

Gerald E. Finken, R.Ph., M.S.
CEO & Pharmacist

Gerald is a licensed pharmacist with almost 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO. Gerald focuses on innovation, disruptive business strategies, and growth opportunities.

Tina Schlecht, PharmD, MBA
Vice President, Pharmacy Operations

Tina joined RxE2 as vice president, pharmacy operations in 2020. She brings with her over 20 years of experience in pharmacy and the biotechnology and pharmaceutical industries. She began her career at Clinical Supplies Management, Inc. (CSM) where she led the growth of Clinical Trials Research Pharmacist (CTRP®) services. She went on to serve as president of Center Point Clinical Services. During her career, she was also employed by the National Community Pharmacists Association, heading the Long-Term Care Division and working on strategic programs, and ProPharma Group, overseeing ICSR (individual case safety reports) processing and regulatory submissions for serious adverse events. Tina received her Bachelor of Science and Doctor of Pharmacy degrees from North Dakota State University and her MBA from the University of Oregon. Her pharmacy practice experience includes community and outpatient pharmacy in addition to clinical research.

The Way We Think About Clinical Research Needs to Change:

RxE2 Began by Asking "Why?"

Why do clinical trials take so long?

Why are clinical trials so expensive?

Why do so many clinical trials fail?

RxE2's Root Cause Solution: 

Pharmacists Unbound™

Expanding the Role of the Pharmacist

E2 Services Reach Everyone Everywhere

The concept of E2 Services took shape when RxE2 looked at the services provided by pharmacies and the relationship the pharmacists have with their patients through the lens of clinical research.

E2 Services are pharmacy-focused, decentralized, and convenient for people everywhere. More than 85% of the population has never participated in a clinical trial, yet almost everyone has been to a pharmacy. E2 Services expand the opportunity to participate in clinical trials to more people by bringing the trials to them.

By focusing on what benefits Everyone, Everywhere, E2 Services address the time, cost, and quality issues that have persisted in the pharmaceutical clinical research industry for the past 40 years.

Coming November 2o20

White Papers

Register with RxE2 and be the first to know when we release white papers or press releases.

Thank You!

Your submission has been received. We will be in touch shortly!

Oops! Something went wrong while submitting the form.

Ready to Implement E2 Services? 

Philanthropy:

RxE2 Gives Back

NorthStar Development Cycling Club

Inspiring Young Cyclists to Excel

NorthStar Development Cycling is a non-profit corporation and a member club of USA Cycling, the organization recognized by the US Olympic Committee to sanction competitive cycling. Students are coached by USA Cycling-licensed and trained coaches. NorthStar was founded, and is managed and coached by volunteers who are enthusiastic to share the thrill of competitive cycling with the next generation.

NorthStar is based in the Twin Cities but has members throughout Minnesota, Wisconsin and Iowa. They train and compete locally and travel as a team to major regional and national junior races.

AI Powered,
Pharmacist-Led

Clinical Trials

RxE2 Pharmacists are pioneering a new standard for time, cost, and quality for the pharmaceutical industry.

5/10 Drugs Approved

E2 Counseling leverages the expertise of RxE2 Pharmacists to gather better information, leading to a 50% approval rate for new drugs.

5-7 Years for Approval

E2 Trials is a new framework for drug approval. RxE2 Pharmacists engage patients, capture medication data, and improve communication—reducing approval timelines by 40%

< $0.5B Development Cost

E2 Trials will commoditize clinical services, delivering results at a fraction of the cost of the traditional clinical trial model.

“I’ve been a member of the program since 2011, first as a new rider, then a coach, and now a leader. As a new rider, I was motivated, but inexperienced, and didn’t know how to navigate the challenges of competition. A friend suggested NorthStar not only because of the excellent opportunities the program offered, but also its focus on personal development. The opportunities included participating in races around the country that exposed me to things I never would overcome alone. Most importantly, it’s the community members, like Gerald Finken, that make up this organization that inspired me as a youth and now as a leader.”

Peter Olejniczak
Executive Director - NorthStar Development Cycling Club

Pharmacist. CEO. National Champion

Gerald Finken has had a life-long passion for cycling, and is a two-time USA Cycling Masters National Cycling Champion

“One of the main reasons I donate to NorthStar is that I know the impact riding a bike with a team has. Once you put the helmet on, the only thing that matters is what is in the legs and race smarts. The team rides consists of young adults to masters cyclist, like me. The conversations in the peloton or group ride focuses on training, competing, what is going on at work or school, what is going on in the world, the beauty of nature while on the ride, and other things that are on our minds. As well as many, many jokes and “trash-talking”!

This exposes these young adults to great conversations and companionship across all age groups. Every young adult I have met who participated on these teams have always just been more mature and aware of life, let alone so many of them able to push me as they go up the road on a climb or as they jump away for sign sprint. One of my fondest experiences with riding with a group was going on a 50 mile group ride. I did not know the ride leader, but he was always at the front pushing the pace. I was drafting so I was able to hang on. By mile 45, we were all tired, but the ride leader was suffering. His head was down, his form not so perfect anymore, and he could barely stay with the group for the last five miles. I was thinking to myself that his “bravado” finally caught up with him and that he needed more experience with pacing to be able to ride 50 miles at 20mph. At the end of the ride, he took off his helmet, gave me a big smile, shook my hand, and very maturely introduced himself. No wonder he faded at 45 miles—he was only 13!!. Five years later he was riding as a US Pro. This young man taught me a very valuable lesson—humility, and once you put a helmet on, legs do the talking.”

Gerald E. Finken
CEO Cyclist, & Pharmacist

AI Powered,
Pharmacist-Led

Clinical Trials

RxE2 Pharmacists are pioneering a new standard for time, cost, and quality for the pharmaceutical industry.

5/10 Drugs Approved

E2 Counseling leverages the expertise of RxE2 Pharmacists to gather better information, leading to a 50% approval rate for new drugs.

5-7 Years for Approval

E2 Trials is a new framework for drug approval. RxE2 Pharmacists engage patients, capture medication data, and improve communication—reducing approval timelines by 40%

< $0.5B Development Cost

E2 Trials will commoditize clinical services, delivering results at a fraction of the cost of the traditional clinical trial model.